Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
FIA investigates near-miss between marshals and Liam Lawson at Mexico City Grand Prix, raising concerns about safety protocols.
Tari Eason's contract uncertainty looms over the Houston Rockets' season, while the Astros face challenges and the Thunder and Lakers navigate their own narratives.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
FIA investigates near-miss between marshals and Liam Lawson at Mexico City Grand Prix, raising concerns about safety protocols.
Tari Eason's contract uncertainty looms over the Houston Rockets' season, while the Astros face challenges and the Thunder and Lakers navigate their own narratives.